AzTrials
AzTrials

Tooth ExtractionNCT07324083

Immediate Implant Loading After Ridge Preservation Using Autogenous Dentin Graft and Beta-Tricalcium Phosphate

A study testing Autogenous Mineralized Dentin Graft and Beta-Tricalcium Phosphate in people with Tooth Extraction and Alveolar Ridge Preservation, run by Soaad Tolba Mohammed Tolba Badawi at 1 site in Egypt.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This randomized controlled clinical trial aimed to evaluate the clinical, radiographic, and histological outcomes of immediate implant loading in extraction sockets preserved using autogenous mineralized dentin graft (AMDG), beta-tricalcium phosphate (β-TCP), or no grafting. Read more about this study

Who is it for?
Ages 18 to 65 years
What is being tested?
Autogenous Mineralized Dentin Graft and Beta-Tricalcium Phosphate
Type of treatment
Surgery or procedure
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
22 participants
Where
1 siteEgypt
Study dates
1 Jan 2023to 1 Aug 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Adults aged 18 years or older
  • Patients requiring extraction of a maxillary premolar tooth
  • Adequate bone height to allow delayed implant placement
  • Good oral hygiene and compliance with follow-up visits
  • Ability to understand the study procedures and provide written informed consent

Who cannot join

  • Presence of uncontrolled systemic diseases that could affect bone healing
  • History of radiotherapy to the head and neck region
  • Heavy smoking
  • Active infection or untreated periodontal disease at the extraction site
  • History of bisphosphonate or other antiresorptive drug use
  • Poor oral hygiene or inability to comply with study protocol

Trial locations and contacts

1 site in 1 country.

Egypt1 site
  • Faculty of Dentistry, Mansoura University

    Al Mansurah

Other trials in Egypt

About this study

Official title: Immediate Implant Loading Following Ridge Preservation: A Randomized Controlled Trial Comparing Autogenous Mineralized Dentin Graft and Beta-Tricalcium Phosphate

This randomized controlled clinical trial aimed to evaluate the clinical, radiographic, and histological outcomes of immediate implant loading in extraction sockets preserved using autogenous mineralized dentin graft (AMDG), beta-tricalcium phosphate (β-TCP), or no grafting. Twenty-two patients requiring extraction of maxillary premolars were enrolled, contributing a total of 27 extraction sites. Sites were randomly allocated into three groups: AMDG, β-TCP, or ungrafted control.

Following socket preservation, dental implants were placed after a 6-month healing period and immediately loaded within 48 hours. Alveolar ridge dimensional changes were assessed using cone-beam computed tomography (CBCT) between implant placement and 2 years post-loading. Implant stability, peri-implant soft tissue health, and probing depths were evaluated at loading and during follow-up visits. Histological evaluation of regenerated bone was performed at the time of implant placement.

The study sought to determine whether AMDG provides comparable or superior outcomes to β-TCP and ungrafted sockets in supporting immediate implant loading.

Read the detailed description

Immediate implant loading requires adequate primary stability and sufficient bone volume and quality. Ridge preservation techniques are therefore critical in maintaining post-extraction socket dimensions. Autogenous dentin grafts have recently gained attention due to their osteoconductive properties, biocompatibility, and cost-effectiveness.

This study compares AMDG with a commonly used synthetic graft material (β-TCP) and ungrafted sockets to assess their influence on ridge preservation, implant stability, peri-implant tissue health, and bone quality under immediate loading conditions.

Being tested
Autogenous Mineralized Dentin Graft, Beta-Tricalcium Phosphate, Control (Ungrafted Socket)
Keywords
Socket preservation, immediate loading, autogenous dentin graft, beta-tricalcium phosphate, dental implant

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Autogenous Mineralized Dentin GraftProcedure or surgery

    Extraction sockets were preserved using AMDG prepared from the patient's own extracted tooth. Implants were placed 6 months post-grafting and immediately loaded within 48 hours.

  • Beta-Tricalcium PhosphateProcedure or surgery

    Extraction sockets were preserved using synthetic β-TCP bone graft. Implants were placed 6 months post-grafting and immediately loaded within 48 hours.

  • Control (Ungrafted Socket)Procedure or surgery

    Extraction sockets were left ungrafted and allowed to heal naturally. Implants were placed 6 months post-extraction and immediately loaded within 48 hours.

Study groups in NCT07324083
Study groupRoleWhat they receive
Autogenous Mineralized Dentin GraftActive comparatorExtraction sockets were preserved using AMDG prepared from the patient's own extracted tooth. Implants were placed 6 months post-grafting and immediately loaded within 48 hours.
Receives: Procedure: Autogenous Mineralized Dentin Graft
Beta-Tricalcium PhosphateActive comparatorExtraction sockets were preserved using synthetic β-TCP bone graft. Implants were placed 6 months post-grafting and immediately loaded within 48 hours.
Receives: Procedure: Beta-Tricalcium Phosphate
Control (Ungrafted Socket)Placebo comparatorExtraction sockets were left ungrafted and allowed to heal naturally. Implants were placed 6 months post-extraction and immediately loaded within 48 hours.
Receives: Procedure: Control (Ungrafted Socket)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Alveolar Ridge Width Change

    Dimensional changes in alveolar ridge width were assessed using CBCT at the center, mesial, and distal sections of each implant site. Measurements were compared between the grafted (AMDG and β-TCP) and control groups over the follow-up period.Unit of Measure: Millimeters (mm)

    Measured: From 6 months post-extraction (implant placement) to 2 years post-loading

Secondary outcomes (4)
  1. Implant Stability Quotient (ISQ)

    Implant stability was assessed using resonance frequency analysis to record ISQ values at each follow-up visit for all groups.Unit of Measure: ISQ units(0-100)

    Measured: At implant loading, 3 months, and 6 months post-loading

  2. Modified Sulcus Bleeding Index (mSBI)

    Peri-implant soft tissue inflammation was evaluated using the mSBI at each follow-up visit for all groups. Unit of Measure: Index score (0-5 scale)

    Measured: At implant loading, 3 months, and 6 months post-loading

  3. Probing Pocket Depth (PPD)

    Probing depth around each implant was measured using a periodontal probe to assess peri-implant tissue health across all groups.Unit of Measure: Millimeters (mm)

    Measured: At implant loading, 3 months, and 6 months post-loading

  4. Histological Bone Quality

    Histological analysis of bone biopsies obtained from grafted and control sites was performed to evaluate bone maturity, remodeling, and osseointegration. Unit of Measure: Qualitative histological score.

    Measured: 6 months post-grafting (at implant placement)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted7 Jan 2026
  2. Study start1 Jan 2023
  3. Primary completion1 May 2025
  4. Study completion1 Aug 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
22 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07324083
Sponsor's protocol ID
R.25.12.95
Status last verified
Dec 2025
First submitted
23 Dec 2025
Last updated
12 Jan 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

A study testing Autogenous Mineralized Dentin Graft and Beta-Tricalcium Phosphate in people with Tooth Extraction and Alveolar Ridge Preservation, run by Soaad Tolba Mohammed Tolba Badawi at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 12 Jan 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Alveolar Ridge Width Change (time frame: From 6 months post-extraction (implant placement) to 2 years post-loading). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 12 Jan 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in